<p>Frontier Capital Management Co. LLC 在最近向证券交易委员会的披露中表示，在第二季度减少了对 Align Technology, Inc. (NASDAQ:ALGN - 免费报告) 的持股比例，降幅为 7.5%。该基金在季度内出售了 18,201 股后，持有该医疗设备提供商的股票 224,025 股。根据其最近向证券交易委员会的备案，Frontier Capital Management Co. LLC 约持有 Align Technology 0.31% 的股份，价值 42,415,000 美元。</p>
<p>获取 <strong>Align Technology</strong> 警报：</p>
<ul>
<li>为什么这三只科技股可能是你忽视的最佳机会</li>
</ul>
<p>其他大型投资者最近也增加或减少了对该公司的持股。Invesco Ltd. 在第一季度将其在 Align Technology 的股份增加了 12.7%。Invesco Ltd. 目前持有该医疗设备提供商的 1,219,715 股股票，价值 193,764,000 美元，此前在上个季度又收购了 137,553 股。Federated Hermes Inc. 在第二季度将其在 Align Technology 的持股增加了 31.0%。Federated Hermes Inc. 目前持有 926,733 股该医疗设备提供商的股票，价值 175,458,000 美元，此前在上个季度又收购了 219,219 股。瑞士银行资产管理公司（UBS AM）在第一季度将其在 Align Technology 的股份增加了 32.2%。瑞士银行资产管理公司目前持有 832,313 股该医疗设备提供商的股票，价值 132,221,000 美元，此前在上个季度又购买了 202,616 股。挪威银行在第二季度收购了 Align Technology 的新头寸，价值约 155,297,000 美元。最后，Navera Investment Management Ltd. 在第二季度将其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd. 目前持有 787,559 股该医疗设备提供商的股票，价值 149,126,000 美元，此前在上个季度又收购了 23,080 股。目前，88.43% 的股票由机构投资者和对冲基金持有。</p>
<h2>Align Technology 股价上涨 3.5%</h2>
<p>Align Technology 股票周四开盘价为 164.58 美元。该股票的 50 日移动平均价格为 139.04 美元，200 日移动平均价格为 155.04 美元。该公司的市值为 118.1 亿美元，市盈率为 31.90，市盈率/增长比率为 1.93，贝塔值为 1.86。Align Technology, Inc. 的一年低点为 122.00 美元，一年高点为 246.19 美元。</p>
<ul>
<li>买入抄底？这些盈利失误提供长期上涨潜力</li>
</ul>
<p>Align Technology (NASDAQ:ALGN - 获取免费报告) 最近在 10 月 29 日（星期三）发布了其财报。该医疗设备提供商报告本季度每股收益 (EPS) 为 2.61 美元，超出分析师一致预期的 2.38 美元，超出幅度为 0.23 美元。Align Technology 的净利润率为 9.50%，股本回报率为 13.96%。该公司本季度的收入为 9.9569 亿美元，而分析师预期为 9.8075 亿美元。去年同期，该公司的每股收益为 2.35 美元。该公司的季度收入同比增长 1.8%。平均而言，股票分析师预测 Align Technology, Inc. 本财年的每股收益将达到 7.98 美元。</p>
<h2>分析师设定新目标价</h2>
<p>ALGN 最近成为多份分析师报告的主题。摩根士丹利在 10 月 30 日的研究报告中将 Align Technology 的目标价从 142.00 美元上调至 154.00 美元，并给予该公司 “持平” 评级。瑞士银行集团在 10 月 16 日的研究报告中将 Align Technology 的目标价从 160.00 美元下调至 155.00 美元，并对该公司设定了 “中性” 评级。Weiss Ratings 在 10 月 8 日的报告中将 Align Technology 的评级从 “持有 (c-)” 下调至 “卖出 (d+)”。华尔街 Zen 在 11 月 8 日的研究报告中将 Align Technology 的评级从 “持有” 上调至 “买入”。最后，Leerink Partners 在 10 月 30 日的研究报告中将 Align Technology 的目标价从 172.00 美元上调至 189.00 美元。一位研究分析师对该股票给予了强烈买入评级，六位分析师给予了买入评级，八位分析师给予了持有评级，两位分析师给予了卖出评级。根据 MarketBeat，Align Technology 目前的共识评级为 “持有”，平均目标价为 175.00 美元。</p>
<ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
<p><strong>查看我们对 Align Technology 的最新股票分析</strong></p>
<h2>Align Technology 公司简介</h2>
<p>（免费报告）</p>
<p>Align Technology, Inc. 设计、制造和销售 Invisalign 隐形矫正器，以及 iTero 口内扫描仪和服务，面向美国、瑞士及国际的正畸医生和普通牙医。该公司的隐形矫正器业务提供全面的产品，包括满足年轻患者正畸需求的 Invisalign 综合套餐，如下颌前移、合规指示器和牙齿萌出补偿；以及针对一般年龄在六到十岁之间的年轻患者的 Invisalign 第一阶段 I 和 Invisalign 第一综合阶段 II 套餐，这是一种初生牙和恒牙的混合。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Align Technology</li>
<li>交易股票：相对强弱指数及其用途</li>
<li>GameStop 看起来破碎：为什么 GME 可能在 2026 年崩溃</li>
<li>如何投资蓝筹股</li>
<li>市场动量：三只有望大幅突破的股票</li>
<li>消费品股票，解析</li>
<li>Casey’s General Stores 将继续上涨的三大理由</li>
</ul>
<p><strong>想看看其他对冲基金持有的 ALGN 吗？</strong> 访问 HoldingsChannel.com 获取 Align Technology, Inc. (NASDAQ:ALGN - 免费报告) 的最新 13F 备案和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在爱齐科技吗？</h2>
<p>在考虑爱齐科技之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而爱齐科技并不在名单上。</p>
<p>虽然爱齐科技目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

爱齐科技

<p>Frontier Capital Management Co. LLC 在第二季度减少了对爱齐科技的持股 7.5%。爱齐科技的股票开盘价为 164.58 美元，市值为 118.1 亿美元。分析师的评级意见不一，普遍持有的共识评级，平均目标价为 175.00 美元。该公司报告第三季度每股收益为 2.61 美元，超出预期，营收同比增长 1.8%</p>

<p>Frontier Capital Management Co. LLC reduced its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 7.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 224,025 shares of the medical equipment provider's stock after selling 18,201 shares during the quarter. Frontier Capital Management Co. LLC owned approximately 0.31% of Align Technology worth $42,415,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Frontier Capital Management Co. LLC 在最近向证券交易委员会的披露中表示，在第二季度减少了对 Align Technology, Inc. (NASDAQ:ALGN - 免费报告) 的持股比例，降幅为 7.5%。该基金在季度内出售了 18,201 股后，持有该医疗设备提供商的股票 224,025 股。根据其最近向证券交易委员会的备案，Frontier Capital Management Co. LLC 约持有 Align Technology 0.31% 的股份，价值 42,415,000 美元。</p>
</div><p>Get <strong>Align Technology</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Align Technology</strong> 警报：</p>
</div><ul>
<li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么这三只科技股可能是你忽视的最佳机会</li>
</ul>
</div><p>Other large investors have also recently added to or reduced their stakes in the company. Invesco Ltd. grew its stake in shares of Align Technology by 12.7% during the first quarter. Invesco Ltd. now owns 1,219,715 shares of the medical equipment provider's stock valued at $193,764,000 after acquiring an additional 137,553 shares in the last quarter. Federated Hermes Inc. grew its holdings in Align Technology by 31.0% during the 2nd quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider's stock worth $175,458,000 after acquiring an additional 219,219 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Align Technology by 32.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 832,313 shares of the medical equipment provider's stock valued at $132,221,000 after purchasing an additional 202,616 shares in the last quarter. Norges Bank acquired a new position in Align Technology in the second quarter worth about $155,297,000. Finally, Navera Investment Management Ltd. increased its holdings in shares of Align Technology by 3.0% in the 2nd quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider's stock valued at $149,126,000 after acquiring an additional 23,080 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他大型投资者最近也增加或减少了对该公司的持股。Invesco Ltd. 在第一季度将其在 Align Technology 的股份增加了 12.7%。Invesco Ltd. 目前持有该医疗设备提供商的 1,219,715 股股票，价值 193,764,000 美元，此前在上个季度又收购了 137,553 股。Federated Hermes Inc. 在第二季度将其在 Align Technology 的持股增加了 31.0%。Federated Hermes Inc. 目前持有 926,733 股该医疗设备提供商的股票，价值 175,458,000 美元，此前在上个季度又收购了 219,219 股。瑞士银行资产管理公司（UBS AM）在第一季度将其在 Align Technology 的股份增加了 32.2%。瑞士银行资产管理公司目前持有 832,313 股该医疗设备提供商的股票，价值 132,221,000 美元，此前在上个季度又购买了 202,616 股。挪威银行在第二季度收购了 Align Technology 的新头寸，价值约 155,297,000 美元。最后，Navera Investment Management Ltd. 在第二季度将其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd. 目前持有 787,559 股该医疗设备提供商的股票，价值 149,126,000 美元，此前在上个季度又收购了 23,080 股。目前，88.43% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Align Technology Trading Up 3.5%</h2>
<div class="lb-trans"><h2>Align Technology 股价上涨 3.5%</h2>
</div><p>Shares of Align Technology stock opened at $164.58 on Thursday. The stock has a 50-day moving average price of $139.04 and a 200 day moving average price of $155.04. The company has a market cap of $11.81 billion, a P/E ratio of 31.90, a P/E/G ratio of 1.93 and a beta of 1.86. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $246.19.</p>
<div class="lb-trans"><p>Align Technology 股票周四开盘价为 164.58 美元。该股票的 50 日移动平均价格为 139.04 美元，200 日移动平均价格为 155.04 美元。该公司的市值为 118.1 亿美元，市盈率为 31.90，市盈率/增长比率为 1.93，贝塔值为 1.86。Align Technology, Inc. 的一年低点为 122.00 美元，一年高点为 246.19 美元。</p>
</div><ul>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>买入抄底？这些盈利失误提供长期上涨潜力</li>
</ul>
</div><p>Align Technology (NASDAQ:ALGN - Get Free Report) last issued its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.38 by $0.23. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company had revenue of $995.69 million during the quarter, compared to analyst estimates of $980.75 million. During the same quarter last year, the business posted $2.35 EPS. The company's revenue for the quarter was up 1.8% on a year-over-year basis. On average, equities analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Align Technology (NASDAQ:ALGN - 获取免费报告) 最近在 10 月 29 日（星期三）发布了其财报。该医疗设备提供商报告本季度每股收益 (EPS) 为 2.61 美元，超出分析师一致预期的 2.38 美元，超出幅度为 0.23 美元。Align Technology 的净利润率为 9.50%，股本回报率为 13.96%。该公司本季度的收入为 9.9569 亿美元，而分析师预期为 9.8075 亿美元。去年同期，该公司的每股收益为 2.35 美元。该公司的季度收入同比增长 1.8%。平均而言，股票分析师预测 Align Technology, Inc. 本财年的每股收益将达到 7.98 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>ALGN has been the subject of a number of analyst reports. Morgan Stanley boosted their price objective on Align Technology from $142.00 to $154.00 and gave the company an &#34;equal weight&#34; rating in a research report on Thursday, October 30th. UBS Group decreased their target price on shares of Align Technology from $160.00 to $155.00 and set a &#34;neutral&#34; rating for the company in a research report on Thursday, October 16th. Weiss Ratings cut Align Technology from a &#34;hold (c-)&#34; rating to a &#34;sell (d+)&#34; rating in a report on Wednesday, October 8th. Wall Street Zen upgraded Align Technology from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, November 8th. Finally, Leerink Partners boosted their price target on Align Technology from $172.00 to $189.00 in a research report on Thursday, October 30th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, Align Technology currently has a consensus rating of &#34;Hold&#34; and an average price target of $175.00.</p>
<div class="lb-trans"><p>ALGN 最近成为多份分析师报告的主题。摩根士丹利在 10 月 30 日的研究报告中将 Align Technology 的目标价从 142.00 美元上调至 154.00 美元，并给予该公司 “持平” 评级。瑞士银行集团在 10 月 16 日的研究报告中将 Align Technology 的目标价从 160.00 美元下调至 155.00 美元，并对该公司设定了 “中性” 评级。Weiss Ratings 在 10 月 8 日的报告中将 Align Technology 的评级从 “持有 (c-)” 下调至 “卖出 (d+)”。华尔街 Zen 在 11 月 8 日的研究报告中将 Align Technology 的评级从 “持有” 上调至 “买入”。最后，Leerink Partners 在 10 月 30 日的研究报告中将 Align Technology 的目标价从 172.00 美元上调至 189.00 美元。一位研究分析师对该股票给予了强烈买入评级，六位分析师给予了买入评级，八位分析师给予了持有评级，两位分析师给予了卖出评级。根据 MarketBeat，Align Technology 目前的共识评级为 “持有”，平均目标价为 175.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on Align Technology</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Align Technology 的最新股票分析</strong></p>
</div><h2>Align Technology Company Profile</h2>
<div class="lb-trans"><h2>Align Technology 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.</p>
<div class="lb-trans"><p>Align Technology, Inc. 设计、制造和销售 Invisalign 隐形矫正器，以及 iTero 口内扫描仪和服务，面向美国、瑞士及国际的正畸医生和普通牙医。该公司的隐形矫正器业务提供全面的产品，包括满足年轻患者正畸需求的 Invisalign 综合套餐，如下颌前移、合规指示器和牙齿萌出补偿；以及针对一般年龄在六到十岁之间的年轻患者的 Invisalign 第一阶段 I 和 Invisalign 第一综合阶段 II 套餐，这是一种初生牙和恒牙的混合。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Align Technology</li>
<li>Trading Stocks: RSI and Why it's Useful</li>
<li>GameStop Looks Broken: Here’s Why GME Could Crash in 2026</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>Consumer Staples Stocks, Explained</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Align Technology</li>
<li>交易股票：相对强弱指数及其用途</li>
<li>GameStop 看起来破碎：为什么 GME 可能在 2026 年崩溃</li>
<li>如何投资蓝筹股</li>
<li>市场动量：三只有望大幅突破的股票</li>
<li>消费品股票，解析</li>
<li>Casey’s General Stores 将继续上涨的三大理由</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ALGN?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 ALGN 吗？</strong> 访问 HoldingsChannel.com 获取 Align Technology, Inc. (NASDAQ:ALGN - 免费报告) 的最新 13F 备案和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Align Technology Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在爱齐科技吗？</h2>
</div><p>Before you consider Align Technology, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑爱齐科技之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而爱齐科技并不在名单上。</p>
</div><p>While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然爱齐科技目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Align Technology, Inc. $ALGN 的股票被 Frontier Capital Management Co. LLC 出售